Nanoli Therapeutics LLC

Minneapolis, MN

UEI
MTYXBAZGW5G5
CAGE
9WDE7
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Asian-Pacific American Owned
  • Limited Liability Company
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
200 SE Oak St, Minneapolis, MN 55455, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Development of NPC1-targeting nanobodies against filovirus infections summary filoviruses, including ebola (ebov)… R41AI197273 National Institute of Allergy and Infectious Diseases (NIH) $300,000

Quick answers

Is Nanoli Therapeutics LLC registered in SAM.gov?

Yes. Nanoli Therapeutics LLC's SAM.gov registration is active through February 23, 2027.

What is Nanoli Therapeutics LLC's most recent federal award?

Nanoli Therapeutics LLC's most recent federal grant award is Development of NPC1-targeting nanobodies against filovirus infections summary filoviruses, including ebola (ebov)… (R41AI197273), from National Institute of Allergy and Infectious Diseases (NIH), on August 10, 2026.

On GovTribe

See Nanoli Therapeutics LLC's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login